Daré Bioscience, Inc.

DARE

NASDAQ

Healthcare

Biotechnology

San Diego, CA, US21 employeesdarebioscience.com

$1.75

-0.15(-8.11%)

Mkt Cap $17M

$1.30

$3.26

52-Week Range

At a Glance

AI-generated

Revenue breakdown: Royalty Revenue (54.3%), License And Collaboration Revenues (30.4%), Milestone Revenue (9.8%).

8-K

Daré Bioscience, Inc. completed the second closing of its previously announced unregistered securities offering on March 6, 2026, as disclosed in this Form 8-K filing dated March 9, 2026. This event falls under Item 3.02, indicating an unregistered sale of equity securities that may impact the company's capitalization and shareholder base.

$17M

Market Cap

-$42.6K

Revenue

-$13M

Net Income

Employees21

Fundamentals

How The Business Makes Money

Revenue by Segment

Royalty Revenue54.3%($20M)

License And Collaboration Revenues30.4%($11M)

Milestone Revenue9.8%($4M)

License5.4%($2M)

Royalty0.1%($35.3K)

Activity

What Changed Recently

Securities Issuance

Mar 8, 2026

Unregistered Sales of Equity Securities. On March 6, 2026, Daré Bioscience, Inc. (“Daré” “we,” “us,” or “our”) completed the second closing of its previously an

Regulation FD

Mar 1, 2026

and Exhibit 99.1 to this report is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as a

Securities Issuance+3 More

Jan 28, 2026

of Current Report on Form 8-K. Item 3.03 Material Modification to Rights of Security Holders. The information set forth in Items 5.03 and 8.01 of this report is

Regulation FD

Jan 5, 2026

and Exhibit 99.1 to this report is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as a

Peer Companies

Company	Price	Change	Market Cap	P/E
PALIPalisade Bio, Inc.	$1.90	+0.80%	$314M	-6.3
ANLAdlai Nortye Ltd.	$8.65	+9.56%	$270M	-1.4
LPTXLeap Therapeutics, Inc.	$0.77	-3.15%	$32M	-2.6
ATHAATHA	$6.75	-6.12%	$27M	—
CTXRCitius Pharmaceuticals, I...	$0.85	+1.30%	$10M	-0.5
HOTHHoth Therapeutics, Inc.	$0.57	+3.25%	$7M	-1.1
AIMDAinos, Inc.	$1.44	+0.00%	$6M	-0.5
ASBPAspire Biopharma Holdings...	$0.97	-3.96%	$3M	—

Analyst View

Company Profile

CIK0001401914

ISINUS23666P2002

CUSIP23666P101

Phone858 926 7655

Address3655 Nobel Drive, San Diego, CA, 92122, US

SEC EDGAR